Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Digital America 2024: Connectivity, Trends, and Transformations

Pulselab.media, a digital media company, today released an insightful overview of the digital landscape in the United States for the year 2024, drawing from comprehensive data and analyses based on a report from Datareportal.com. This report highlights the current state of internet usage, social media engagement, mobile connectivity, and internet speeds, offering an invaluable resource for understanding digital trends and behaviors across the nation.Digital connectivity at a glance · The United States has achieved a remarkable internet penetration rate of 97.1%, with 331.1 million

Speqta appoints Gustav Norberg as CFO

Speqta AB (publ) ("Speqta") has today decided to appoint Gustav Norberg as CFO for Speqta. He will assume the position on February 29, 2024. Speqta has today decided to appoint Gustav Norberg as CFO for Speqta. Since January 2023, Gustav has been responsible for the finance function at BrightBid and hence has deep knowledge of Speqta's business. He has also been a central part of the merger between BrightBid and Speqta. Gustav has previous experience from, among others, ICA Gruppen and Nordic Cinema Group in various parts of the finance function. Gustav has a bachelor's degree

Shape Robotics is releasing multiannual 2024 – 2027 strategic plan – “Preparing today’s generation for the future”

Company Announcement no. 06-24Copenhagen, February 28, 2024 The announcement contains inside information. Shape Robotics is finalizing and releasing its long term* strategic plan aiming to support the growing confidence of its investors, partners, and employees. The new plan is focused on further expanding and strengthening Shape Robotics’ business model, by emphasizing its core values interlinked with the continued disciplined and high-performance execution, as proven in the past years**. The company is closely following already ongoing projects as well as new ones aimed at

Strategic evaluation of Fortaco’s marine, energy, and heavy project businesses ongoing

Fortaco has started a strategic evaluation of its marine, energy, and heavy project business. These business areas represented less than 10 per cent of overall net sales in 2023 and had negative EBITDA. The Fortaco business sites operating in these segments are located in Finland, Hungary, and Serbia. The strategic evaluation is expected to be completed during H1 2024. Further information Lars Hellberg  President & CEO, Fortaco Group    +358 40 572 9488    lars.hellberg@fortacogroup.com

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 28 February 2024 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 28 February 2024 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

Annual Report and ESG Report 2023

Fornebu, 28[th] February 2024, Ocean Yield AS ("Ocean Yield" or the "Company") publishes its fourth quarter 2023 results, the 2023 Annual Report and ESG Report for 2023. The results and management comments for the fourth quarter can be found on pages 88-94 in the Annual Report. HIGHLIGHTS FOR Q4 2023 · EBITDA for Q4 2023 was USD 55.3 million and Adjusted EBITDA was USD 88.2 million. · Net profit for Q4 2023 was USD 23.3 million. · Strong balance sheet, with an equity ratio of 28.2% and USD 115.8 million in cash. · During the quarter, the Company agreed to acquire a 2016-

Result of General Meeting

28 February 2024 Everest Global plc (“EG” or the “Company”) Results of General Meeting   EG announces that all of the resolutions set out in the notice of General Meeting and brought before the General Meeting held at 11 am today were duly passed. +--+----------------------------+----------+------+-------+-----+--------+-----+|  |Resolution |For |% |Against|% |Withheld|% |+--+----------------------------+----------+------+-------+-----+--------+-----+|1.|To receive the annual |28,744,301|99.955|0 |0 |13,019 |0.045||

Remedy Entertainment Plc: Inside Information: Remedy acquires full rights to the Control franchise from 505 Games

Remedy Entertainment Plc Inside Information February 28, 2024 at 7:00 p.m. EET   Inside Information: Remedy acquires full rights to the Control franchise from 505 Games    Today, Remedy Entertainment Plc (“Remedy”) and 505 Games S.p.A. (“505 Games”) announce a transaction upon which all publishing, distribution, marketing and other rights to Control, codename Condor, Control 2, and all future Control products will revert to Remedy.    The Control franchise is in the core of Remedy. Having acquired the full rights to Control, Condor and Control 2, Remedy is now in a

Diagonal Bio appoints Karin Wehlin as new CEO

Diagonal Bio AB (publ.) (“Diagonal Bio” or “the Company”) is pleased to announce that the Board of Directors has appointed Karin Wehlin as Chief Executive Officer (CEO) of Diagonal Bio. Karin Wehlin is currently Diagonal Bio’s interim CEO.Karin Wehlin was elected to the Board of Directors of Diagonal Bio in the spring of 2023, and on November 23, 2023, she was appointed as interim CEO. Karin holds an Executive MBA degree from Lund University and has completed education at INSEAD in Strategy, Innovation, and Leadership. She has over 25 years of experience in senior positions within the Life

Read original

Citycon Group successfully places a EUR 300 million Green Bond with an orderbook approximately seven times over-subscribed

CITYCON OYJ    Stock Exchange Release     28 February 2024 at 18:50 hrsNOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO OR TO ANY PERSON LOCATED IN OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER THE "UNITED STATES"), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Citycon Group has successfully placed a EUR 300 million green bond (the "Bond"). The issuer of the Bond is Citycon Treasury B.V.

Notice to attend the extraordinary general meeting of Diagonal Bio AB

Shareholders in Diagonal Bio AB, 559248-8984, are hereby invited to attend an extraordinary general meeting on Tuesday, 2nd of April, 2024, at 13:00 CET at The Spark, conference room 10, Medicon Village, Scheeletorget 1 Lund.Right to Participate and Notification Shareholders who wish to participate at the extraordinary general meeting must: · be registered as a shareholder in the share register maintained by Euroclear Sweden AB on Thursday, March 21[st], 2024, and · notify the company no later than Monday, March 25[th], 2024, by email to egm@diagonalbio.com. Notifications can

Read original

The Board of Directors decides on a preferential rights issue of units in order to finance future development

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE THIS PRESS RELEASE IS DISTRIBUTABLE WOULD BE ILLEGAL OR REQUIRE ADDITIONAL ACTIONS THAN SUCH ACTIONS RESULTING FROM SWEDISH LAW. SEE THE “IMPORTANT INFORMATION” SECTION AT THE END OF THIS PRESS RELEASE.The Board of Directors of Diagonal Bio AB ("Diagonal Bio" or the "Company") has today, on February 28, 2024, resolved to carry out an issue of units

Read original

#24-75 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-74 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Diagonal Bio AB Year-end Report 2023

“Looking back at 2023, I am proud to point out the significant steps we have made in our development, including the key achievements such as the CE-marking of LAMPlify® according to Low Voltage Directive (LVD) 2006/95/ EC. A highlight of our fourth quarter was the commencement of LAMPlify® commercialisation.” says, Karin Wehlin, interim CEO Diagonal Bio AB.Summary of Year-end Report 2023 2023-10-01 — 2023-12-31 (October — December) • Net sales amounted to 23 KSEK (0 KSEK), capitalised development contributed with 405 KSEK (846 KSEK), while other operating income amounted to 7 KSEK (3

Read original

Arctic Bioscience – Treatment start for 519 patients in the HeROPA-study

With reference to the stock exchange announcement from 17. January 2024 which reported that the HeROPA phase IIb clinical trial in mild-to-moderate psoriasis was fully recruited with the planned 519 patients, Arctic Bioscience are pleased to report that 519 patients are now dosed with the Investigational Medicinal Product HRO350 or placebo. After all patients have been dosed for 6 months, the primary endpoint will be read out.The HeROPA trial is randomized, double blind and placebo controlled, investigating the efficacy and safety of the novel, oral drug candidate HRO350 for the treatment

Bulletin from Sivers Semiconductors AB (publ)’s Extraordinary General Meeting on 28 February 2024

The Extraordinary General Meeting in Sivers Semiconductors AB (publ) (the “Company”) has been held on 28 February 2024 and in particular the following decisions were resolved.The general meeting resolved that the board of directors would, until the end of the next annual general meeting, consist of five members elected by the general meeting without deputies. Further, the general meeting resolved that the annual general meeting’s resolution from 25 May 2023 on remuneration amounting to a total of SEK 2,520,000, of which SEK 1,050,000 to the chairman of the board and SEK 350,000 to each of

Replacement - Update to 2024 Financial Calendar

The following amendments have been made to the 'Update to Faron’s Financial Calendar for 2024' announcement released on 27 February 2024 at 1:00 p.m. EST / 6:00 p.m. GMT / 8:00 p.m. EET under RNS No 6663E.   -          Replacement wording included. -          Change of date of the Company’s AGM and publication of 2023 financial statement. -          Reasoning for change of date of publishing financial statement release for the full year 2023 and Annual Report 2023, including financial statements for the full year. -          Wording on defined terms.   All other details

1st Quarter Results

Regulatory Announcement Royal Bank of Canada February 28, 2024 First Quarter 2024 Earnings Release The First Quarter 2024 Earnings Release has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. First Quarter 2024 Earnings Release dated February 28, 2024 http://www.rns-pdf.londonstockexchange.com/rns/8401E_1-2024-2-28.pdf A copy of the First Quarter 2024 Earnings Release

There are no items matching the current filter
There are no more items matching the current filter
Back to top